Bromide

Bromide

SCHEMBL3881997

Br.CN(C)CCc1ccccc1

nearest known ligand 0.95

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
SIGMAR1 known ✓ Q99720 4/20 0.65
TAAR1 Q96RJ0 6/20 0.95
AOC3 Q16853 3/20 0.64
HRH3 Q9Y5N1 1/20 0.62
CHRNA7 P36544 1/20 0.55
ALDH1A1 P00352 1/20 0.54
TSHR P16473 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL29033194 1.00 TAAR1 (0.95) TAAR1SIGMAR1AOC3HRH3CHRNA7
SCHEMBL22863888 0.97 TAAR1 (1.00) TAAR1SIGMAR1AOC3HRH3CHRNA7
SCHEMBL168948 0.97 TAAR1 (1.00) TAAR1SIGMAR1AOC3HRH3CHRNA7
Hydrochloric Acid SCHEMBL4354648 0.95 TAAR1 (0.95) TAAR1SIGMAR1AOC3HRH3CHRNA7
Water SCHEMBL9747156 0.95 TAAR1 (0.95) TAAR1SIGMAR1AOC3HRH3CHRNA7
Methyl Alcohol SCHEMBL9781334 0.93 TAAR1 (0.91) TAAR1SIGMAR1AOC3HRH3CHRNA7
Methyl Alcohol SCHEMBL28673594 0.91 TAAR1 (0.86) TAAR1SIGMAR1AOC3HRH3CHRNA7
Ethylene SCHEMBL27562091 0.91 TAAR1 (0.86) TAAR1SIGMAR1AOC3HRH3CHRNA7
Bromide SCHEMBL5091341 0.86 SIGMAR1 (0.80) TAAR1SIGMAR1AOC3
Acetic Acid SCHEMBL8653585 0.85 TAAR1 (0.76) TAAR1SIGMAR1AOC3HRH3ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105218606-B A kind of method for preparing scutellarin 昆明理工大学 2017-12-01 CN claimed
CN-105218606-A A kind of method preparing scutellarin UNIV KUNMING SCIENCE & TECHNOLOGY 2016-01-06 CN claimed
CN-119143628-A Four-center Schiff base metal compound and preparation method and application thereof 中国科学院长春应用化学研究所 2024-12-17 CN disclosed
CN-118085254-A Eight-center Schiff base metal catalyst and preparation method thereof and preparation method of polyglycolic acid 中国科学院长春应用化学研究所 2024-05-28 CN disclosed
CN-105777463-B A kind of β, γ-beta-unsaturated esters compound preparation method 大连理工大学 2019-01-18 CN disclosed
CN-105218606-B A kind of method for preparing scutellarin 昆明理工大学 2017-12-01 CN disclosed
CN-105777463-A Preparation method of beta, gamma-unsaturated ester compound 大连理工大学 2016-07-20 CN disclosed
CN-105218606-A A kind of method preparing scutellarin UNIV KUNMING SCIENCE & TECHNOLOGY 2016-01-06 CN disclosed
CN-103314004-B New preparation method of 5,7-pregnadiene-3,20-dione-diethyl ketal TAIZHOU HISOUND CHEMICAL COMPANY LTD 2015-07-08 CN disclosed
US-7560585-B2 Process for preparing (S)- alpha-cyano-3-phenoxybenzyl-(S)-2-(4-chlorophenyl)-isovalerate COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2009-07-14 US disclosed
CN-100467443-C 6-(aryl-amido or aryl-amidomethyl)-naphthalen-2-yloxy-acidic derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1) WYETH CORP (US) 2009-03-11 CN disclosed
CN-1289478-C Process for preparing allyl sulfone derivatives and intermediates for preparing such compounds SUMITOMO CHEMICAL CO (JP) 2006-12-13 CN disclosed
US-20060128982-A1 Process for preparing (S)- alpha-cyano-3-phenoxybenzyl-(S)-2-(4-chlorophenyl)-isovalerate COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH 2006-06-15 US disclosed
CN-1543453-A 6- (aryl-amido or aryl-amidomethyl) -naphthalen-2-yloxy-acid derivatives as plasminogen activator inhibitor type 1 (PAI-1) 2004-11-03 CN disclosed
CN-1520399-A Process for prepn. of allyl sulfone derivatives and intermediates for prepn. 住友化学工业株式会社 2004-08-11 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060128982-A1 Process for preparing (S)- alpha-cyano-3-phenoxybenzyl-(S)-2-(4-chlorophenyl)-isovalerate PCCA, CHRNE, CHRNB4 SIGMAR1 1543/4885TAAR1 3417/4885AOC3 2681/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.